0
0
0
Medicare IVIG Access Enhancement Act
12/30/2022, 5:47 PM
Summary of Bill HR 3808
Bill 117 HR 3808, also known as the Medicare IVIG Access Enhancement Act, is a piece of legislation introduced in the US Congress. The purpose of this bill is to improve access to intravenous immunoglobulin (IVIG) therapy for Medicare beneficiaries.
IVIG therapy is a treatment used for a variety of conditions, including immune deficiencies, autoimmune diseases, and certain neurological disorders. However, there have been challenges in ensuring that Medicare beneficiaries have access to this important therapy.
The Medicare IVIG Access Enhancement Act aims to address these challenges by establishing a demonstration project that would provide Medicare coverage for IVIG therapy in the home setting. This would allow beneficiaries to receive treatment in the comfort of their own homes, rather than having to travel to a healthcare facility. Additionally, the bill includes provisions to improve data collection and reporting on IVIG utilization, as well as measures to ensure that Medicare reimbursement rates for IVIG are adequate to cover the cost of the therapy. Overall, the Medicare IVIG Access Enhancement Act seeks to improve access to IVIG therapy for Medicare beneficiaries, while also addressing issues related to reimbursement and data collection. This legislation has the potential to benefit many individuals who rely on IVIG therapy for their medical conditions.
IVIG therapy is a treatment used for a variety of conditions, including immune deficiencies, autoimmune diseases, and certain neurological disorders. However, there have been challenges in ensuring that Medicare beneficiaries have access to this important therapy.
The Medicare IVIG Access Enhancement Act aims to address these challenges by establishing a demonstration project that would provide Medicare coverage for IVIG therapy in the home setting. This would allow beneficiaries to receive treatment in the comfort of their own homes, rather than having to travel to a healthcare facility. Additionally, the bill includes provisions to improve data collection and reporting on IVIG utilization, as well as measures to ensure that Medicare reimbursement rates for IVIG are adequate to cover the cost of the therapy. Overall, the Medicare IVIG Access Enhancement Act seeks to improve access to IVIG therapy for Medicare beneficiaries, while also addressing issues related to reimbursement and data collection. This legislation has the potential to benefit many individuals who rely on IVIG therapy for their medical conditions.
Congressional Summary of HR 3808
Medicare IVIG Access Enhancement Act
This bill requires the Centers for Medicare & Medicaid Services to establish a five-year demonstration project to evaluate the benefits of providing Medicare coverage and payment for items and services needed for the in-home administration of intravenous immune globulin to treat chronic inflammatory demyelinating polyneuropathy or multifocal motor neuropathy. Beneficiary participation shall be voluntary.
Read the Full Bill
Current Status of Bill HR 3808
Bill HR 3808 is currently in the status of Bill Introduced since June 11, 2021. Bill HR 3808 was introduced during Congress 117 and was introduced to the House on June 11, 2021. Bill HR 3808's most recent activity was Referred to the Subcommittee on Health. as of June 14, 2021
Bipartisan Support of Bill HR 3808
Total Number of Sponsors
1Democrat Sponsors
1Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
30Democrat Cosponsors
20Republican Cosponsors
10Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 3808
Primary Policy Focus
HealthAlternate Title(s) of Bill HR 3808
Medicare IVIG Access Enhancement Act
To provide for a demonstration project to further examine the benefits of providing coverage and payment for items and services necessary to administer intravenous immune globulin (IVIG) in the home, and for other purposes.
Medicare IVIG Access Enhancement Act
Comments
Sponsors and Cosponsors of HR 3808
Latest Bills
To authorize the Secretary of Education, in collaboration with the Secretary of Health and Human Services, to establish an interagency advisory Commission on Advancing Restorative Justice in Elementary and Secondary Education, and for other purposes.
Bill HR 8360April 17, 2026
To amend the Higher Education Act of 1965 to remove all adverse credit history related to a loan from the credit history of a borrower who has rehabilitated the loan.
Bill HR 8361April 17, 2026
To reauthorize the YouthBuild program, and for other purposes.
Bill HR 8333April 17, 2026
To raise the Foreign Service mandatory retirement age by aligning it with the Social Security Full Retirement Age, and for other purposes.
Bill HR 8346April 17, 2026
To amend the FISA Amendments Act of 2008 to extend the authorities of title VII of the Foreign Intelligence Surveillance Act of 1978 through April 30, 2026, and for other purposes.
Bill HR 8322April 17, 2026
To amend title II of the Social Security Act to repeal the retirement earnings test, and for other purposes.
Bill HR 8344April 17, 2026
To amend section 133 of title 23, United States Code, to remove a certain State funding set-aside for transportation alternative programs, and for other purposes.
Bill HR 8349April 17, 2026
To amend title XI of the Social Security Act to require the Center for Medicare and Medicaid Innovation to test a model to reduce chronic diseases by using accountable produce is medicine.
Bill HR 8355April 17, 2026
To amend the Federal Food, Drug, and Cosmetic Act to enhance drug manufacturing amount information reporting, and for other purposes.
Bill HR 8339April 17, 2026
Supporting the designation of the week of April 11 through April 17, 2026, as "Black Maternal Health Week", founded by Black Mamas Matter Alliance, Inc. (BMMA), to bring national attention to the maternal and reproductive health crisis in the United States and the importance of reducing maternal mortality and morbidity among Black women and birthing people.
Bill HRES 1183April 17, 2026